Evidence map›Paper›PMID 34671051›Full record

ArticleNature communications2021

Longitudinal functional imaging of VIP interneurons reveals sup-population specific effects of stroke that are rescued with chemogenetic therapy.

Mohamad Motaharinia, Kim Gerrow, Roobina Boghozian, Emily White, Sun-Eui Choi, Kerry R Delaney, Craig E Brown

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rethinking Remapping: Circuit Mechanisms of Recovery after Stroke.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  12. Article
  13. Article
  14. Two-photon calcium imaging of neuronal activity.Nature reviews. Methods primers · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mohamad Motaharinia *Division of Medical Sciences, University of Victoria, Victoria, BC, V8P 5C2, Canada.
Kim Gerrow *Division of Medical Sciences, University of Victoria, Victoria, BC, V8P 5C2, Canada.
Roobina BoghozianDivision of Medical Sciences, University of Victoria, Victoria, BC, V8P 5C2, Canada.
Emily WhiteDivision of Medical Sciences, University of Victoria, Victoria, BC, V8P 5C2, Canada.
Sun-Eui ChoiDivision of Medical Sciences, University of Victoria, Victoria, BC, V8P 5C2, Canada.
Kerry R DelaneyDepartment of Biology, University of Victoria, Victoria, BC, Canada.
Craig E BrownDivision of Medical Sciences, University of Victoria, Victoria, BC, V8P 5C2, Canada. brownc@uvic.ca.ORCID 0000-0002-0076-2414
University of Victoria · CAUniversity of British Columbia Hospital · CA

Funding

CIHR
6 · The paper itself

Abstract

Stroke profoundly disrupts cortical excitability which impedes recovery, but how it affects the function of specific inhibitory interneurons, or subpopulations therein, is poorly understood. Interneurons expressing vasoactive intestinal peptide (VIP) represent an intriguing stroke target because they can regulate cortical excitability through disinhibition. Here we chemogenetically augmented VIP interneuron excitability in a murine model of photothrombotic stroke and show that it enhances somatosensory responses and improves recovery of paw function. Using longitudinal calcium imaging, we discovered that stroke primarily disrupts the fidelity (fraction of responsive trials) and predictability of sensory responses within a subset of highly active VIP neurons. Partial recovery of responses occurred largely within these active neurons and was not accompanied by the recruitment of minimally active neurons. Importantly, chemogenetic stimulation preserved sensory response fidelity and predictability in highly active neurons. These findings provide a new depth of understanding into how stroke and prospective therapies (chemogenetics), can influence subpopulations of inhibitory interneurons.

Indexed as

AnimalsClozapineHumansInterneuronsMiceNeural InhibitionReceptor, Muscarinic M3Recovery of FunctionSomatosensory CortexStrokeVasoactive Intestinal PeptideClozapineclozapine N-oxideReceptor, Muscarinic M3Vasoactive Intestinal Peptide

Identifiers

PMID34671051
PMCPMC8528851
OpenAlexW3206757781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.